Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in biomarker dealmaking
2.1. Introduction
2.2. Biomarker deals over the years
2.3. Most active biomarker dealmakers
2.4. Biomarker deals by deal type
2.5. Biomarker deals by therapy area
2.6. Biomarker deals by industry sector
2.7. Deal terms for biomarker deals
2.7.1 Biomarker deals headline values
2.7.2 Biomarker deal upfront payments
2.7.3 Biomarker deal milestone payments
2.7.4 Biomarker royalty rates

Chapter 3 – Leading biomarker deals
3.1. Introduction
3.2. Top biomarker deals by value

Chapter 4 – Most active biomarker dealmakers
4.1. Introduction
4.2. Most active biomarker dealmakers
4.3. Most active biomarker deals company profiles

Chapter 5 – Biomarker contracts dealmaking directory
5.1. Introduction
5.2. Biomarker contracts dealmaking directory

Chapter 6 – Biomarker dealmaking by technology type

Deal directory

Deal directory – Biomarker deals by company A-Z
Deal directory – Biomarker deals by deal type
Deal directory – Biomarker deals by therapy area

Deal type definitions

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

?
Table of figures

Figure 1: Biomarker deals since 2016
Figure 2: Active biomarker dealmaking activity – 2016 - 2023
Figure 3: Biomarker deals by deal type since 2016
Figure 4: Biomarker deals by therapy area since 2016
Figure 5: Biomarker deals by industry sector since 2016
Figure 6: Biomarker deals with a headline value
Figure 7: Biomarker deals with an upfront value
Figure 8: Biomarker deals with a milestone value
Figure 9: Biomarker deals with a royalty rate value
Figure 10: Top biomarker deals by value since 2016
Figure 11: Most active biomarker dealmakers 2016 - 2023
Figure 12: Biomarker deals by technology type since 2016